Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study
International Journal of Stroke · 2025
DOI: 10.1177/17474930251322372 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Stroke, 2025. Verfasst von Frederick Ewbank und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Hauptthemen laut MEDLINE: Aspirin, Subarachnoid Hemorrhage, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Acetylsalicylic acid (aspirin) is known to increase the risk of bleeding throughout the body. However, there is also evidence to suggest that acetylsalicylic acid may have a protective role in the formation and rupture of intracranial aneurysms. Previous studies investigating acetylsalicylic acid and subarachnoid hemorrhage (SAH) have so far provided conflicting results.
Aims
The aim of this study was to analyze the Nurse’s Health Study (NHS) using serial assessments to evaluate differences in rates of SAH in those participants taking acetylsalicylic acid and those not taking acetylsalicylic acid while considering dose, frequency, and duration as well as different types of SAH.
Methods
The NHS is a prospective population-based cohort study of female nurses. Information on acetylsalicylic acid was first reported in 1980 until 2016 and included acetylsalicylic acid use, dose, frequency, and duration. All stroke cases were classified by physicians. Cox proportional-hazards regression models were used to estimate the hazard ratio (HR) associated with acetylsalicylic acid use.
Results
A total of 117,648 NHS participants were eligible for analysis with 357 cases of SAH observed over 4,091,239 years of follow-up. There was no association between acetylsalicylic acid use and SAH (HR = 1.02; 95% confidence interval (CI) = [0.82, 1.28], p = 0.85), aneurysmal SAH (1.04; 95% CI = [0.78, 1.39], p = 0.78), or idiopathic SAH (HR = 0.94; 95% CI = [0.65, 1.34], p = 0.72). The number of acetylsalicylic acid tablets per week was associated with SAH (HR = 1.03; 95% CI = [1.00, 1.06], p = 0.02), specifically fatal SAH (HR = 1.04 [1.00, 1.08], p = 0.03). There was no association between frequency and SAH (HR = 1.06; 95% CI = [0.99, 1.13], p = 0.07).
Conclusion
There was no evidence to support a protective association between acetylsalicylic acid and either SAH or aneurysmal SAH in female participants. In fact, there was some evidence to suggest increased SAH risk with increased acetylsalicylic acid dose in some but not all analyses. Data access statement: Data are available by request from the Brigham and Women’s Hospital, Harvard Medical School, and Harvard T.H. Chan School of Public Health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- Faculty of Medicine, University of Southampton, Southampton, UK.
ORCID-Profile: Frederick Ewbank, Diederik Bulters
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Ewbank, F., Hall, S., Gaastra, B., & Bulters, D. (2025). Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study. International Journal of Stroke. https://doi.org/10.1177/17474930251322372
Vancouver
Ewbank F, Hall S, Gaastra B, Bulters D. Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study. International Journal of Stroke. 2025. doi:10.1177/17474930251322372
BibTeX
@article{Ewbank2025,
author = {Ewbank, Frederick and Hall, Samuel and Gaastra, Benjamin and Bulters, Diederik},
title = {Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study},
journal = {International Journal of Stroke},
year = {2025},
doi = {10.1177/17474930251322372}
}
EUVIMED